Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;44(2):324-332.
doi: 10.12122/j.issn.1673-4254.2024.02.15.

[PCID2 is highly expressed in gastric cancer and affects the prognosis by regulating cancer cell cycle and proliferation]

[Article in Chinese]
Affiliations

[PCID2 is highly expressed in gastric cancer and affects the prognosis by regulating cancer cell cycle and proliferation]

[Article in Chinese]
N Zhang et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To investigate the expression of PCI Domain Containing 2 (PCID2) in gastric cancer, its effect on gastric cancer cell cycle and proliferation and the possible molecular mechanisms.

Methods: We examined PCID2 expression levels in gastric cancer and adjacent tissues from 100 patients undergoing radical gastrectomy in our hospital between January, 2012 and December, 2016, and analyzed the correlation of PCID2 expression level with cancer progression and postoperative 5-year survival rate of the patients. GO enrichment analysis was performed to identify the possible pathways that mediated the effect of PCID2 in gastric cancer progression. The effects of lentivirus-mediated PCID2 knockdown and overexpression on cell proliferation and cell cycle were analyzed in gastric cancer MGC-803 cells and in nude mice.

Results: PCID2 was highly expressed in gastric cancer tissues and positively correlated with peripheral blood levels of CA19-9 and CEA (P < 0.01). In gastric cancer patients, a high PCID2 expression was associated with a significantly lowered postoperative 5-year survival rate (P < 0.001) as an independent risk factor for postoperative survival (HR: 2.987, 95% CI: 1.616-5.519). The sensitivity, specificity, and area under the curve of PCID2 for predicting postoperative 5-year survival were 76.74%, 75.44%, and 0.755 (P < 0.001), respectively. GO enrichment analysis suggested that PCID2 was associated with gastric cancer cell cycle progression. PCID2 overexpression in MGC-803 cells significantly promoted cell proliferation, G1/S phase transition, expressions of cyclin D1 and CDK6, and the growth of transplanted xenograft in nude mice (P < 0.05). The expressions of p27 and p16 were significantly lowered in gastric cancer tissues, and their expression levels were negatively regulated by PCID2 expression in MGC-803 cells (P < 0.05).

Conclusion: PCID2 is highly expressed in gastric cancer tissues in close correlation with poor prognosis of the patients. High PCID2 expression promotes gastric cancer proliferation and cell cycle progression by inhibiting the expression of p27 and p16.

目的: 探讨扩增基因PCI结构域2(PCID2)在胃癌中的表达情况及其对细胞周期进程和增殖的影响,并分析其可能的分子机制。

方法: 纳入2012年1月~2016年12月在我院接受胃癌根治术的患者100例,检测胃癌和癌旁组织中PCID2的表达差异;统计学分析PCID2表达水平对胃癌进展及术后5年生存率的影响;采用GO富集分析预测PCID2参与胃癌恶性进展的可能作用途径;体外采用慢病毒转染特异性敲低和过表达胃癌细胞系(MGC-803)中PCID2表达,并分析其对细胞增殖及周期的影响;进一步通过裸鼠移植瘤模型进行在体验证;最后通过组织样本分析结合体内外研究,分析PCID2影响胃癌细胞的分子机制。

结果: 相较于癌旁组织,PCID2在胃癌组织中高表达(P < 0.01);胃癌组织中PCID2表达水平与外周血中CA19-9及CEA水平呈正相关(P < 0.001);以胃癌组织中PCID2相对表达水平(IOD值)的中位数(3.085)为界,将纳入研究的患者分为PCID2高表达组(n=50)和PCID2低表达组(n=50),PCID2高表达组患者术后5年生存率显著低于PCID2低表达组(P < 0.001);单因素结合Cox多因素分析表明胃癌组织中PCID2高表达是影响患者术后5年生存率的独立危险因素(HR:2.987,95% CI:1.616-5.519);ROC曲线分析显示,以PCID2相对表达水平(3.035)为截点值,评估胃癌患者术后5年生存率的敏感性为76.74%,特异性为75.44%,曲线下面积为0.755(P < 0.001)。GO功能富集分析提示PCID2可能与胃癌细胞周期进程有关(P < 0.01)。体外实验证实,PCID2过表达可促进胃癌细胞增殖、G1/S期转变和细胞周期相关蛋白(CyclinD1、CDK6)的表达,而敲低则反之(P < 0.05)。裸鼠成瘤实验证明,PCID2过表达可促进裸鼠移植瘤的生长,而敲低则抑制(P < 0.05)。组织样本分析联合体内外研究表明,胃癌组织中p27、p16蛋白表达水平较癌旁组织均明显降低(P < 0.05)。此外,PCID2过表达抑制细胞周期调控蛋白p27、p16的表达,敲低则相反(P < 0.05)。

结论: PCID2在胃癌组织中高表达且与患者预后不良密切相关,其可能通过抑制p27、p16表达促进胃癌细胞增殖和细胞周期进程。

Keywords: PCID2; cell cycle; gastric cancer; prognosis; proliferation.

PubMed Disclaimer

Figures

图 1
图 1
PCID2在胃癌组织及癌旁组织中的细胞定位与表达情况 Localization and expression of PCID2 in gastric cancer (GC) and adjacent tissues. A: Immunohistochemical staining of PCID2. B: Relative IOD values of PCID2 expression. C: Relative mRNA values of PCID2 expression. ##P < 0.01 vs adjacent.
图 2
图 2
胃癌组织中PCID2表达水平与CA19-9及CEA水平的相关性分析 Correlation analysis between the expression level of PCID2 in GC and the levels of CA19-9 and CEA in peripheral blood. A: Correlation analysis between PCID2 and CA19-9. B: Correlation analysis between PCID2 and CEA.
图 3
图 3
PCID2表达水平与患者胃癌根治术后5年生存率的关系 Relationship between PCID2 expression level and 5-year survival rate of GC patients after radical operation.
图 4
图 4
PCID2表达水平对胃癌患者根治术后5年生存率的评估价值 Evaluation of the predictive value of PCID2 expression level for 5-year survival rate of GC patients after radical operation.
图 5
图 5
PCID2对胃癌细胞周期进程及增殖的影响 Effect of PCID2 expression level on cell cycle progression and proliferation of GC cells. A: GO function enrichment analysis of PCID2 in GC. B, C: Western blotting for verifying efficiency of PCID2 knock-down and overexpression. D: CCK-8 assay for assessing the proliferation of GC cells. E, F: Flow cytometry for analyzing cell cycle distribution of GC cells. G, H: Western blotting for detecting expressions of cell cycle-related proteins in GC cells. NC: Normal control. Si: SiRNA. LV: Overexpression. *P < 0.05 vs NC, **P < 0.01 vs NC.
图 6
图 6
PCID2对裸鼠皮下成瘤能力的影响 Effect of PCID2 expression level on subcutaneous tumor growth in nude mice. A: Representative pictures of the tumors from the nude mice in each group. B: Comparison of tumor volume in each group. C: Comparison of tumor weight in each group. D, E: Western blotting for detecting expressions of cell cycle-related proteins in tumors of the nude mice. *P < 0.05 vs NC, **P < 0.01 vs NC.
图 7
图 7
p27蛋白、p16蛋白在胃癌组织和癌旁组织中的表达情况及PCID2对其表达的影响 Expressions of p27 and p16 proteins in GC and adjacent tissues and the influence of PCID2 on their expression. A, B: Immunohistochemical staining for detecting expression levels of p27 protein in GC tissues and adjacent tissues. C, D: Immunohistochemical staining for detecting expression levels of p16 protein in GC tissues and adjacent tissues. E, F: Western blotting for detecting expression levels of p27 and p16 protein in GC tissues and adjacent tissues. G, H: Western blotting for detecting expression levels of p27 and p16 proteins in GC cells with PCID2 overexpression and knockdown. I, J: Western blotting for detecting expression levels of p27 and p16 proteins in tumors of the nude mice. #P < 0.05 vs GC, ##P < 0.01 vs GC; *P < 0.05 vs NC, **P < 0.01 vs NC.

Similar articles

References

    1. Tan P, Yeoh KG. Genetics and molecular pathogenesis of gastric adenocarcinoma. Gastroenterology. 2015;149(5):1153–62. e3. doi: 10.1053/j.gastro.2015.05.059. - DOI - PubMed
    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CACancer J Clin. 2021;71(3):209–49. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013;11(5):531–46. doi: 10.6004/jnccn.2013.0070. - DOI - PubMed
    1. Song ZY, Wu YY, Yang JB, et al. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626. - PubMed
    1. Wei XD, Liu X, Liu HM, et al. BRCA1-associated protein induced proliferation and migration of gastric cancer cells through MAPK pathway. Surg Oncol. 2020;35:191–9. doi: 10.1016/j.suronc.2020.08.007. - DOI - PubMed

Publication types